The Endocannabinoid System (ECS)
The ECS is an active and complex cell interaction network composed of chemical neurotransmitters (the endocannabinoids) that bind to a large web of receptors (CB1 and CB2) distributed throughout the body, and then broken down by metabolic enzymes.
Currently, two types of cannabinoid receptors have been identified, the CB1 and CB2 receptors. They differ in the way they transmit signals and their distribution throughout the body.
Activation of cannabinoid receptors leads to inhibition of adenyl cyclase, which prevents the conversion of ATP to cyclic AMP (cAMP). Both CB1 and CB2 belong to the extensive family of G protein-coupled receptors.
There are several important aspects to consider before consuming products with CBD. Cannabinoid treatments can have multiple benefits, but you need to know both the condition and the patient to recommend the most appropriate product. Some important aspects to consider are: